Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals

Cellular and Molecular Immunology

Volumn 14, Issue 1, 2017, Pages 118-126

  Bezbradica, Jelena S ^a   Coll, Rebecca C ^a   Schroder, Kate ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

inflammasome; NLRP3; sterile inflammation; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CELL ACTIVATION; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CROSS PRESENTATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CROSS-PRIMING; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE, INBRED C57BL; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85007591521     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2016.11     Document Type: Article

References (36)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435.
2. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157: 1013-1022.
3. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
4. Kapetanovic R, Bokil NJ, Sweet MJ. Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: a ticking time bomb in ageing. Ageing Res Rev 2015; 24: 40-53.
5. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. K (+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013; 38: 1142-1153.
6. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009; 459: 433-436.
7. Ketelut-Carneiro N, Silva GK, Rocha FA, Milanezi CM, Cavalcanti-Neto FF, Zamboni DS et al. IL-18 triggered by the Nlrp3 inflammasome induces host innate resistance in a pulmonary model of fungal infection. J Immunol 2015; 194: 4507-4517.
8. Chen KW, Schroder K. Antimicrobial functions of inflammasomes. Curr Opin Microbiol 2013; 16: 311-318.
9. Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, Monack DM. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 2010; 207: 1745-1755.
10. Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog 2011; 7: e1002452.
11. Broderick L, De Nardo D, Franklin BS, Hoffman HM, Latz E. The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol 2015; 10: 395-424.
12. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241.
13. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010; 11: 897-904.
14. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008; 9: 857-865.
15. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493: 674-678.
16. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009; 183: 792-796.
17. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791.
18. Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 2014; 1319: 82-95.
19. Vande Walle L, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 2014; 512: 69-73.
20. Duong BH, Onizawa M, Oses-Prieto JA, Advincula R, Burlingame A, Malynn BA et al. A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity. Immunity 2015; 42: 55-67.
21. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009; 5: 487-497.
22. Schweneker K, Gorka O, Schweneker M, Poeck H, Tschopp J, Peschel C et al. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome. Immunobiology 2013; 218: 664-673.
23. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
24. Chow MT, Duret H, Andrews DM, Faveeuw C, Moller A, Smyth MJ et al. Type I NKT-cell-mediated TNF-alpha is a positive regulator of NLRP3 inflammasome priming. Eur J Immunol 2014; 44: 2111-2120.
25. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002; 2: 364-371.
26. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
27. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267: 2000-2003.
28. Schroder K, Irvine KM, Taylor MS, Bokil NJ, Le Cao KA, Masterman KA et al. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci USA 2012; 109: E944-E953.
29. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011; 34: 213-223.
30. Chen KW, Bezbradica JS, Groβ CJ, Wall AA, Sweet MJ, Stow JL et al. The murine neutrophil NLRP3 inflammasome is activated by soluble but not particulate or crystalline agonists. Eur J Immunol 2016; e-pub ahead of print 1 February 2016; doi:10.1002/eji.201545943.
31. Schroder K, Sagulenko V, Zamoshnikova A, Richards AA, Cridland JA, Irvine KM et al. Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology 2012; 217: 1325-1329.
32. Lin KM, Hu W, Troutman TD, Jennings M, Brewer T, Li X et al. IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation. Proc Natl Acad Sci USA 2014; 111: 775-780.
33. Fernandes-Alnemri T, Kang S, Anderson C, Sagara J, Fitzgerald KA, Alnemri ES. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J Immunol 2013; 191: 3995-3999.
34. He WT, Wan H, Hu L, Chen P, Wang X, Huang Z et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res 2015; 25: 1285-1298.
35. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526: 660-665.
36. Kayagaki N, Stowe IB, Lee BL, O'Rourke K, Anderson K, Warming S et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015; 526: 666-671.